Do you have general questions about MOLST? Do you want to learn more about using MOLST appropriately for individuals with intellectual or developmental disabilities (I/DD), including navigating the Surrogate Court Procedures Act (SCPA) §1750-b process? Do you want to ensure your patients’ end-of-life wishes are honored or are wondering what your role is in the MOLST completion process? If you answered “Yes” to any of these questions, please consider attending ECHO MOLST + eMOLST and/or ECHO MOLST for Individuals with I/DD. Videoconferencing clinics meet for 1 hour once a week for 8 weeks. There is no cost to attend! Clinic series schedules are as follows:
Day of Week||
ECHO MOLST for Individuals with I/DD ||
ECHO MOLST + eMOLST||
Interested in joining ECHO MOLST + eMOLST and/or ECHO MOLST for Individuals with I/DD? Email Meg.Greco@excellus.com.
ECHO, which stands for Extension for Community Healthcare Outcomes, is an all-teach-all-learn telementoring model that uses case-based learning. Specialists and experts at a “hub” meet regularly with clinicians at “spokes” via videoconferencing to support in the delivery of specialty care services. To learn more about the ECHO model and its history, watch this short video by Project ECHO’s founder, Dr. Sanjeev Arora and visit hsc.unm.edu/echo.
ECHO MOLST + eMOLST was launched in Fall 2018 and has been running biannually since then as a platform for sustainable MOLST education. Through clinic series evaluations, case presentations and participant feedback, it became apparent that additional education was needed on the MOLST completion process for individuals with I/DD. New this fall we are launching a 2nd ECHO MOLST clinic, ECHO MOLST for Individuals with I/DD, to provide education on special considerations and MOLST completion elements unique to these individuals.
The aims of ECHO MOLST + eMOLST are to provide sustainable MOLST education and to improve the quality of thoughtful MOLST discussions and documentation to ensure patient preferences are honored. The goal of ECHO MOLST for Individuals with I/DD is to increase the frequency of thoughtful end-of-life discussions for seriously ill individuals with I/DD who are appropriate MOLST, ensuring conversations occur earlier in the disease trajectory before an emergency occurs.
Weekly hour-long clinics begin with brief introductions and a short 15-minute didactic presentation given by one of our subject matter experts. This is followed by a 35 to 40-minute real patient case presentation given by a “spoke” using a Q&A and discussion format.
Upon completion of the 8-week ECHO MOLST + eMOLST clinic series, attendees will:
• Use MOLST for the appropriate patient population
• Describe the differences between standard medical care, advance directives and MOLST
• Utilize a standardized 8-Step MOLST protocol to ensure accurate completion
• Improve their comfort level with end-of-life conversations
• Describe benefits of eMOLST vs. paper MOLST in terms of quality & patient safety – and much more!
Upon completion of the 8-week ECHO MOLST for Individuals with I/DD clinic series, attendees will:
• Recognize SCPA §1750-b process outlined on the OPWDD legal requirements checklist and know when and how it needs to be completed before the MOLST can be signed by a physician
• Use MOLST appropriately for individuals with I/DD
• Recognize the value of health care proxy completion for individuals with I/DD
• Improve their comfort level with end-of-life conversations with individuals with I/ DD and their family members and caregivers – and much more!
Data collected using a pre-test, post-test method proves that ECHO MOLST works. Scores have consistently shown that through participation in a clinic series, attendees significantly increase their knowledge of the MOLST process, including identification of incompatible medical orders and understanding that MOLST is not an advance directive. Furthermore, attendees recognize the importance of their own advance care planning, with health care proxy completion rates among participants rising an average of 26 percent. To date, ECHO MOLST has provided end-of-life education to over 1,200 participants from 150+ health care organizations across New York State. This spread of knowledge is ensuring that patient preferences are honored and that the quality of end-of-life care New Yorkers receive is continually improving.
Don’t miss out on these 2 important educational opportunities. For more information on ECHO MOLST + eMOLST and ECHO MOLST for Individuals with I/DD, including objectives and who should attend, visit molst.org/training/echo or contact Meg.Greco@excellus.com to enroll today!
AMA Designation Statement
Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Designation Statement
Project ECHO® designates this live activity for a maximum of 1.0 ANCC contact hour. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation.
Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.
None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Patricia Bomba, MD, MACP, FRCP; Katie Orem, MPH; Meg Greco, MPA; Sara Butterfield, RN, BSN, CPHQ, CCM; Carolyn Kazdan, MHSA, NHA; Eileen Zibell, JD; Sheila Shea, Esq.; Paul Partridge, PhD; Lisa Volpe, JD; Erica Berman, M Ed; Wendy Tigchelaar; Philip Dzwonczyk, MD; Kris Marks, LCSW-R, OSW-C; Brenda Stevens, RN, CHPN
Binghamton University, SUNY, College of Community and Public Affairs, Department of Social Work is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0143.
Binghamton University, SUNY, College of Community and Public Affairs, Department of Social Work is a CSWE nationally accredited MSW program.